Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Inhibition of protein kinase C/Twist1 signaling augments anticancer effects of androgen deprivation and enzalutamide in prostate cancerMasaki Shiota, Akira Yokomizo, Ario Takeuchi, et al.
Oncogenesis|November 30, 2017
Doxycycline induces apoptosis via ER stress selectively to cells with a cancer stem cell-like properties: importance of stem cell plasticityTakashi Matsumoto, Takeshi Uchiumi, Keisuke Monji, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 13, 2020
Genomic characteristics revealed by targeted exon sequencing of testicular germ cell tumors in Japanese menTakashi Matsumoto, Masaki Shiota, Takeshi Uchiumi, et al.
JAMA Network Open|February 23, 2019
Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or AbirateroneMasaki Shiota, Shintaro Narita, Shusuke Akamatsu, et al.
The Journal of Antimicrobial Chemotherapy|October 25, 2020
Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistanceMasamune Aihara, Ruriko Nishida, Masaru Akimoto, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|March 9, 2019
Toxic myopathy with multiple deletions in mitochondrial DNA associated with long-term use of oral anti-viral drugs for hepatitis B: A case studyTakayuki Fujii, Kei-Ichiro Takase, Hiroyuki Honda, et al.
Journal of Molecular Endocrinology|March 29, 2013
Human heterochromatin protein 1 isoforms regulate androgen receptor signaling in prostate cancerMomoe Itsumi, Masaki Shiota, Akira Yokomizo, et al.
The Journal of Pathology|January 21, 2003
Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcomaYoshinao Oda, Yoshihiro Ohishi, Tsuyoshi Saito, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2019
The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese menMasaki Shiota, Naohiro Fujimoto, Shigehiro Tsukahara, et al.
The Prostate|June 3, 2020
High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancerMomoe Itsumi, Masaki Shiota, Yohei Sekino, et al.
Pageof 16